| Literature DB >> 31908542 |
Tuanjai Mahatumarat1, Napaporn Pinmanee2, Wichchulada Injai2, Romanee Chaiwarith1.
Abstract
BACKGROUND: Intravenous antibiotics, either as outpatient parenteral antimicrobial therapy (OPAT) or transition of care to community-based management, is a common practice in tertiary care hospitals to minimize hospital stays. However, infectious disease consultation was not mandated for those prescriptions. Therefore, we conducted this study to evaluate the appropriateness of intravenous antibiotic prescriptions at hospital discharge.Entities:
Keywords: antimicrobial stewardship; outpatient parenteral antimicrobial therapy; parenteral antimicrobials
Year: 2019 PMID: 31908542 PMCID: PMC6929924 DOI: 10.2147/DHPS.S221430
Source DB: PubMed Journal: Drug Healthc Patient Saf ISSN: 1179-1365
Characteristics of 117 Patients Receiving Intravenous Antibiotics at Hospital Discharge
| Characteristics | Number of Patients (%) (N=117) |
|---|---|
| Age (years, median, IQR) | 60 (50,73) |
| Males | 44 (37.6) |
| Underlying diseases | |
| Hypertension | 36 (30.8) |
| Solid malignancy | 33 (28.2) |
| Heart disease | 25 (21.3) |
| Diabetes mellitus | 24 (20.5) |
| Chronic kidney disease | 24 (20.5) |
| Cirrhosis | 9 (7.7) |
| Systemic lupus erythematosus | 7 (6.0) |
| Hematologic malignancy | 4 (3.4) |
| Chronic obstructive pulmonary diseases | 4 (3.4) |
| Diagnosis for intravenous antibiotics | |
| Upper urinary tract infection | 40 (34.2) |
| Hepatobiliary tract infections | 18 (15.4) |
| Pneumonia | 14 (12.0) |
| Fever of unknown etiology | 10 (8.6) |
| Skin and soft tissue infection | 7 (6.0) |
| Catheter-related bloodstream infections | 6 (5.1) |
| Septic arthritis | 6 (5.1) |
| Spontaneous bacterial peritonitis | 4 (3.4) |
| Tracheobronchitis | 3 (2.6) |
| Febrile neutropenia | 3 (2.6) |
| Gastroenteritis | 2 (1.7) |
| Bacteremia | 2 (1.7) |
| Central nervous system infection | 1 (0.9) |
Notes: Data are presented as number (%), or median (IQR) as appropriate. Hepatobiliary tract infections included liver abscess, cholangitis, post-operation of endoscopic retrograde cholangio-pancreatography. Pneumonia included community-acquired pneumonia, hospital-acquired pneumonia, healthcare-associated pneumonia, and obstructive pneumonitis. Skin and soft tissue infections included cellulitis, abscess, infected wound, and infected skin and soft tissue around permanent pacemakers. Infections of the central nervous system included meningitis, and brain abscess.
Abbreviation: IQR, interquartile range.
Pathogens Isolated from Urine and Blood of 117 Patients
| Pathogens | Number (%) (N=117) |
|---|---|
| Pathogen identified from urine culture | 37 (31.6) |
| | 26 (70.2) |
| ESBL-producing | 19 (51.3) |
| ESBL-producing | 4 (10.8) |
| | 2 (5.4) |
| Pathogen identified from hemoculture | 33 (28.2) |
| | 16 (48.5) |
| ESBL-producing | 6 (18.2) |
| | 5 (15.2) |
| ESBL-producing | 1 (3.0) |
| | 5 (15.2) |
| Other gram-negative bacteria | 3 (9.1) |
| | 2 (6.0) |
| Methicillin-susceptible | 1 (3.0) |
| | 1 (3.0) |
| | 1 (3.0) |
Notes: Nine patients had the same organisms in urine and blood cultures i.e. four for E. coli, four for ESBL-producing E.coli, and one for ESBL-producing K.pneumoniae.
Intravenous Antibiotics at Hospital Discharge
| Antibiotics | Number of Prescriptions (%) (N=129) |
|---|---|
| Β-lactams | |
| Ceftriaxone | 47 (36.4) |
| Ertapenem | 26 (20.1) |
| Meropenem | 14 (10.8) |
| Piperacillin/tazobactam | 9 (7.0) |
| Ceftazidime | 5 (3.9) |
| Ampicillin | 5 (3.9) |
| Cefazolin | 3 (2.3) |
| Amoxicillin/clavulanate | 2 (1.6) |
| Imipenem/cilastatin | 2 (1.6) |
| Penicillin G sodium | 1 (0.8) |
| Metronidazole | 7 (5.4) |
| Vancomycin | 4 (3.1) |
| Ciprofloxacin | 2 (1.6) |
| Clindamycin | 1 (0.8) |
| Gentamicin | 1 (0.8) |
Appropriateness of Intravenous Antibiotics for 129 Prescriptions
| Appropriateness | Number of Prescriptions (%) (N=129) |
|---|---|
| Inappropriate use | 110 (85.3) |
| No indication for antibiotic use | 14 (10.9) |
| Can switch to oral antibiotics | 68 (52.7) |
| Ineffective against isolated pathogens | 1 (0.8) |
| Can be de-escalated to narrower spectrum | 14 (10.9) |
| Incorrect dosage | 1 (0.8) |
| Incorrect duration | 21 (16.3) |